Anniina Koski - Concepedia

Author

Anniina Koski

Helsinki University Hospital ORCID

Also Known As

A Koski, A. Koski, Anniina Koski, Anniina Koski-Palken, Anniina Koski-Palkén, Anniina Koski-Pàlken, Koski Anniina

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Helsinki University Hospital University of Helsinki Docrates Cancer Center Oncos Therapeutics (Finland)Institute for Molecular Medicine Finland

About

Anniina Koski is an author at Helsinki University Hospital specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	171
2	Natural Sciences	1	1	11
3	Biochemistry	1	1	11
4	Cell Biology	1	1	11
5	Hepatology	1	1	11

Anniina Koski

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF Anniina Koski, Lotta Kangasniemi, Sophie Escutenaire, Molecular Therapy	2010	246
Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF–Coding Oncolytic Adenovirus Anna Kanerva, Petri Nokisalmi, Iulia Diaconu, Clinical Cancer Research	2013	175
Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients Ilkka Liikanen, Laura Ahtiainen, Mari Hirvinen, Molecular Therapy	2013	161
Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus Vincenzo Cerullo, Iulia Diaconu, Lotta Kangasniemi, Molecular Therapy	2011	158
Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy Otto Hemminki, Suvi Parviainen, Juuso Juhila, Oncotarget	2015	85
Oncolytic adenovirus based on serotype 3 Otto Hemminki, Gerd Bauerschmitz, Silvio Hemmi, Cancer Gene Therapy PathologyVirologyMedicineViral GeneticsOncolytic Adenovirus	2010	64
Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy Ilkka Liikanen, Anniina Koski, Maiju Merisalo-Soikkeli, OncoImmunology	2015	58
Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM‐CSF: <scp>R</scp>esults <i>in vitro</i>, in rodents and in humans Simona Bramante, Johanna K. Kaufmann, Ville Veckman, International Journal of Cancer	2015	56
ADHD desynchronizes brain activity during watching a distracted multi-talker conversation Juha Salmi, Mostafa Metwaly, Jussi Tohka, NeuroImage	2019	51
Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans Simona Bramante, Anniina Koski, Anja Kipar, International Journal of Cancer Tumor BiologyCancer ImmunosurveillanceMalignant DiseaseOncogenic AgentMedicine	2013	44

Page 1